Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 16th May 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Tylan 200 injection recalled owing to sterility concerns
A product recall alert has been issued for Tylan 200 mg/ml Solution for Injection.
Wholesalers and vets urged to examine their inventory immediately

A product recall alert has been issued for Tylan 200 mg/ml Solution for Injection owing to concern about the product’s sterility.

The Veterinary Medicines Directorate (VMD) writes: ‘We wish to make wholesalers and veterinary surgeons aware that Elanco UK AH Ltd has issued a recall of Tylan 200mg/ml Solution for Injection (Vm 00006/4098) due to a failed periodic revalidation (media fill test) that may affect the level of sterility assurance of certain products.’

The recall affects batch no. C967336A, expiry date 07/2020. Elanco is in the process of contacting wholesalers and veterinary surgeons urging them to examine their inventory immediately and quarantine affected products.

The VMD continues: ‘This issue only applies to the batch listed above. Any other batches of Tylan 200 Injection are not impacted and may continue to be distributed. For further information regarding the recall, please contact Ms Victoria Haslingden 01256 779519 or email elanco_orders@lilly.com’

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.